William Febbo | CEO and Director |
Ed Stelmakh | CFO and COO |
Stephen Silvestro | Chief Commercial Officer |
Ryan Daniels | William Blair |
Joy Zhang | SVB Securities |
Sean Dodge | RBC Capital Markets |
Eric Martinuzzi | Lake Street |
Marc Wiesenberger | B. Riley Securities |
Jeff Garro | Piper Sandler |
Good afternoon, everyone. Thank you for joining OptimizeRx's Second Quarter Fiscal 2022 Earnings Discussion. With us today is the Chief Executive Officer, OptimizeRx, William Febbo. He is joined by company's Chief Financial Officer, Ed Stelmakh; Chief Commercial Officer, Steve Silvestro; General Counsel and Chief Compliance Officer; Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D'Silva. At the conclusion of today's earnings call, I will provide some important cautions regarding the forward-looking statements made by management during today's call.